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Zoonotic infections transmitted from marine mammals to humans in European Arctic are of unknown 39 
significance, despite considerable potential for transmission due to local hunt and a rapidly changing 40 
environment. As an example, brucellosis may have significant impact on human health due to 41 
consumption of raw meat or otherwise contact with tissues and fluids of infected game species such 42 
as muskoxen and polar bears. Here we present serological results for Baffin Bay polar bears (Ursus 43 
maritimus) (n = 96) and North East Greenland muskoxen (Ovibos moschatus) (n = 32) for antibodies 44 
against Brucella spp. The analysis was a two-step trial initially using the Rose Bengal Test (RBT), 45 
followed by confirmative competitive enzyme-linked immunosorbent assays of RBT-positive 46 
samples. No muskoxen had antibodies against Brucella spp, while antibodies were detected in six 47 
polar bears (6.25%) rendering a seroprevalence in line with previous findings in other Arctic regions. 48 
Seropositivity was not related to sex, age or biometrics i.e. size and body condition. Whether the 49 
detected polar bear Brucella spp. antibodies found in polar bears were due to either prey spill over or 50 
true recurrent Brucella spp. infections is unknown. Our results therefore highlight the importance of 51 
further research into the zoonotic aspects of Brucella spp. infections, and the impact on wildlife and 52 
human health in the Arctic region. 53 
 54 




The Arctic ecosystem is subject to several interacting anthropogenic stressors that cause cumulative 57 
stress in humans and wildlife, which may in turn lead to increased susceptibility to zoonotic infections 58 
(Atwood et al. 2017; Jenssen et al. 2015; Greer et al. 2008; Hueffer et al. 2011; Sonne 2010). In some 59 
human populations in the Arctic, it is common to consume raw or insufficiently heat-treated wildlife 60 
and game meat (Tryland et al. 2013). The importance of heat-treatment is exemplified by studies of 61 
toxoplasmosis in North America, where 80% of examined humans were seropositive in an Inuit 62 
community with dietary preference for raw meat, as opposed to 10% seropositivity within a local 63 
Cree population having dietary preference for cooked foods (Lévesque et al 2007; Messier et al. 64 
2009). Marine mammals including polar bears, are an important food source for people in the Arctic, 65 
yet the burden of zoonotic pathogens in these species remains largely unknown in most Arctic 66 
regions. While human cases of trichinosis and digital mycoplasmosis (“seal-finger”) are typically 67 
reported (Rodahl 1952; Tryland et al. 2013), the pathogen-spectrum has rarely been addressed by 68 
systematic studies. In addition to marine mammals, muskoxen are also an important food resource in 69 
some parts of the Arctic. For example, in Greenland alone more than 2,000 muskoxen and 150 polar 70 
bears are harvested annually (Piniarneq 2016). In addition to dietary exposure, Arctic hunters are in 71 
frequent physical contact with raw tissues and fluids of hunted wildlife, most often lacking any 72 
preventive measures against transmission of zoonotic pathogens. Information about the occurrence 73 
of wildlife transmitted zoonotic diseases in the Arctic parts of Europe is generally limited (Jenkins et 74 
al. 2013; Tryland et al. 2013), while it has been studied more intensively in Arctic Canada (Campagna 75 
et al. 2011; Goyette et al. 2014; Lévesque et al. 2007; Messier et al. 2012; Sampasa-Kanyinga et al. 76 
2013). 77 
Brucella spp. are zoonotic Gram-negative coccobacilli causing the disease brucellosis in 78 
humans and animals such as domestic ruminants, pigs, and dogs (Fraser 1991; Godfroid et al. 2011; 79 
Metcalf et al. 1994) and in Arctic mammals including polar bears (Ursus maritimus) and muskoxen 80 
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(Ovibos moschatus) (Atwood et al. 2017; Godfroid 2002; Godfroid et al. 2011; Nymo et al. 2011). 81 
Although brucellosis is rarely fatal, depending on the Brucella spp. and host, it may cause a range of 82 
pathological processes such as mastitis, abortion, orchitis, and osteomyelitis (Davis 1990; Enright 83 
1990; Ross et al. 1994; Brew et al. 1999; Prenger-Berninghoff et al. 2008; Siebert et al. 2009, 2017). 84 
Specific species of Brucella are rarely reported for marine mammals since there exist no specific or 85 
validated serological tests (Godfroid 2002). Culture or DNA isolation and sequencing can overcome 86 
problems of cross-reactivity, but such samples are rarely available in relation to wildlife sample 87 
collection. The wide spread zoonotic B. suis biovar 4, also called “rangiferine brucellosis”, has 88 
however been reported in muskoxen previously (Gates et al. 1984; Tomaselli et al. 2016). 89 
As information regarding brucellosis in wildlife and the associated zoonotic risks are generally 90 
sparse for Greenland, the present study aimed at determining the seroprevalence of Brucella spp. 91 
exposure in West Greenland polar bears (U. maritimus) and East Greenland muskoxen (O. 92 
moschatus) to have a first assessment of the risk associated with handling, storage and consumption 93 
of these species.  94 
 95 
Materials and methods 96 
Sampling of polar bears 97 
The sampling locality of polar bears from the West Greenland Baffin Bay subpopulation is shown in 98 
Figure 1. Serum samples (n = 96; Table 1) were obtained during a 5 years period (2009-2013) between 99 
Savissivik (ca. 76 ̊ 20 ́ N) and Uummannaq (ca. 70 ̊ 14 ́ N) (Laidre et al. 2012; SWG 2016). Polar 100 
bears were immobilised and handled according to standard procedures using 5-10 m Zoletil ® (200 101 
mg/ml i.m.) from helicopter as described by Stirling et al. (1989). During immobilisation, blood 102 
samples were drawn from the femoral vein and a vestigial premolar (pm1) tooth was extracted for 103 
determination of individual age from analysis of incremental layers in the cementum. Blood samples 104 
were taken in plain vacutainers and following clotting, the blood was centrifuged at 1100g for 5 min. 105 
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The serum was pipetted off and transferred to cryovials, immediately frozen and stored at –20°C until 106 
analysis. Standard body measurements (standard length and axillary girth in cm) were taken and total 107 
body mass was estimated using the approach by Derocher and Wiig (2002). In the field, general body 108 
condition of individual polar bears was visually estimated on a scale from 1 to 5 according to Stirling 109 
et al. (2008), where 1 and 5 represent the leanest and most obese bears, respectively. According to 110 
this scale, polar bears in categories 3 and 4 are in “good condition”. The individual age estimations 111 
were carried out by counting the cementum growth layer groups (GLGs) of the lower right rudimental 112 
premolar after decalcification, sectioning (14 µm) and staining with toluidine blue as described by 113 
Dietz et al. (1991). Polar bears were categorized as: cub of the year (COY), yearlings, two-year-old 114 
cubs, sub-adults and adults. Adult males were those ≥6 years of age, and adult females were ≥5 years 115 
of age according to Rosing-Asvid et al. (2002).  116 
 117 
Sampling of muskoxen 118 
Figure 1 shows the sampling locality of muskoxen. Serum samples from muskoxen (n = 32; Table 2) 119 
were obtained during two surveys for the study of muskox spatial ecology in North East Greenland, 120 
Zackenberg Valley, in 2013 and 2015. The muskoxen were immobilised and handled according to 121 
standard procedures described in Mosbacher et al. (2016) and Schmidt et al. (2016). Briefly, 122 
muskoxen were immobilized from the ground using a combination of etorphine, xylazine, 123 
medetomidine, and ketamine. Doses were for a 200 kg female muskox were: 2 mg (0.01 mg/kg i.m.) 124 
etorphine (Captivon 9.8 mg/ml; Wildlife Pharmaceuticals, White River, South Africa), 30 mg (0.15 125 
mg/kg) xylazine (Rompun dry substance 500 mg; Bayer Animal Health, Denmark), 0.3 mg (0.0015 126 
mg/kg) medetomidine (Zalopine 30 mg/ml; Orion Pharma Animal HealthDenmark) and 40 mg (0.2 127 
mg/kg) ketamine (Ketaminol 100 mg/ml; MSD Animal Health, Denmark). Doses were supplemented 128 
with sterile water for injection and absolute ethanol to prevent freezing. Resultant total volumes were 129 
1.5 ml and a concentration of 20 % ethanol. Blood samples were taken from the jugular vein in plain 130 
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vacutainers and following clotting, the blood was centrifuged at 1100g for 5 min after which the 131 
serum was pipetted off and transferred to cryovials that were immediately frozen and stored at –20°C 132 
until analysis. The body condition score for muskoxen was determined by estimating the amount of 133 
soft tissue on rump, thorax and withers by palpation (Gerhart et al. 1996). Muskox age determination 134 
was based on horn development according to Olesen and Thing (1993). Only adult muskox 135 
individuals (aged 4 years of age or more) were handled and sampled. 136 
 137 
Serological analyses 138 
No specific or validated serological tests for Brucella infection in marine mammals have been 139 
developed and the detection of specific antibodies is based on tests used in terrestrial mammals 140 
(Godfroid 2002; Sonne et al. 2018). In an attempt to avoid problems of cross-reactivity and false-141 
positives, two serological tests: the Rose Bengal Test (RBT) and the competitive-enzyme linked 142 
immuno-sorbent assay (C-ELISA), were performed to identify Brucella spp. antibodies in serum. 143 
According to the OIE Terrestrial Manual, the C-ELISA can eliminate some but not all false positive 144 
reactions due to cross-reacting bacteria such as Yersinia enterocolitica O:9 . According  to the Manual 145 
of Diagnostic Tests and Vaccines for Terrestrial Animals (Eloit and Schmitt 2017), the RBT is 146 
recommended as a general purpose diagnostic test in all wildlife species while the C-ELISA appear 147 
to be useful for seroepidemiological surveys in wildlife (Stack et al. 1999).    148 
All samples were initially screened with a commercial RBT (PrioCHECK Brucella Rose 149 
Bengal Test, Prionics AG, Zürich, Switzerland), according to the manufacturer’s instructions. In 150 
brief, one drop of test serum (30 µl), and one drop of Rose Bengal antigen were transferred to the test 151 
circle on the slide and mixed thoroughly. The slide was rotated for 4 minutes whilst examined for 152 
agglutination. A positive and negative control were used in each test run. Positive samples were 153 
confirmed with C-ELISA (SVANOVA Biotech AB, Uppsala, Sweden)  according to the 154 
manufacturer’s instructions. In brief, 45 µl of sample dilution buffer was added into each well used 155 
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for serum samples, serum controls and conjugate controls, and 5 µl of positive, weak positive, and 156 
negative serum controls were added into appropriate wells. All control sera were run in duplicates. 157 
Five microliters of test sample were added in duplicates to the wells, and 50 µl of mAb-Solution were 158 
added to all wells used for controls and samples. The plates were incubated in 37ºC for 30 minutes. 159 
After incubation the plate was rinsed with buffer, and 100 µl Conjugate Solution were added into 160 
each well, followed by a second incubation at room temperature for 30 minutes. The plate was rinsed, 161 
and 100 µl Substrate Solution were added to each well and incubated for 10 minutes at room 162 
temperature before adding 50 µl Stop Solution to each well. 163 
Optical density (OD) was assessed at 450 nm using a microplate photometer (air as blank) and 164 
the percent (%) of inhibition (PI) was calculated as: 165 
𝑃𝑃𝑃𝑃 = 100 −  
(𝑂𝑂𝑂𝑂 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑜𝑜𝑜𝑜 𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑜𝑜𝑜𝑜𝑠𝑠 × 100)
𝑂𝑂𝑂𝑂 𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑠𝑠𝑐𝑐𝑠𝑠 𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑜𝑜𝑜𝑜𝑠𝑠
 166 
Finally, the results were interpreted as negatives (PI < 30%) and positives (PI ≥ 30%). A sample was 167 
regarded as seropositive to Brucella when it tested positive in both RBT and C-ELISA. 168 
 169 
Results 170 
None of the muskoxen tested positive for Brucella spp. antibodies by the RBT, and were thus not 171 
analysed in the C-ELISA. Of the polar bears, 7 animals (7.3 %) tested positive in the RBT, while the 172 
C-ELISA confirmed that 6 (6.3%) of the polar bears were true seropositive (Figure 2).  The six polar 173 
bears with antibodies against Brucella spp. included one adult male sampled in 2010, two adult 174 
females sampled in 2010 and 2012, two sub-adults sampled in 2011 (male) and 2012 (female) and 175 
one yearling (male) sampled in 2010. Brucella spp. positive sero-status thus appeared equally 176 





Our findings are comparable with data for these species from other Arctic regions (Tryland et al. 180 
2001; Rah et al. 2005; O’Hara et al. 2010; Godfroid, 2012). Tryland et al. (2001) found a 181 
seroprevalence of 5.4% for Brucella spp. in 297 polar bears from Svalbard and the Barents Sea 182 
collected from 1990-1998, while a seroprevalence ranging from 5-17% was found in polar bears from 183 
Alaska (n = 500) and Canada (n = 275) collected between 2003 and 2006 and from 1982 to 1999, 184 
respectively (O’Hara et al. 2010; Rah et al. 2005). As in our study, the serological screenings of polar 185 
bears from Alaska did not shown any relationship between serostatus, sex and age of the bears (Rah 186 
et al. 2005). In contrast to this, the study on polar bears from Beaufort Sea revealed a higher 187 
seroprevalence in females than males (17 vs. 11%) and showed to be highest in animals aged 1-5 188 
years (14%; n = 96; Rah et al. 2005).  189 
The (sub)species of Brucella spp. bacteria involved and the source of infection in polar bears 190 
have been disputed (Godfroid 2012).  Indirect measures of brucellosis such as antibody tests, are in 191 
general best supported by the isolation of Brucella spp., by which culture or genetic sequencing 192 
renders a valid suggestion of taxonomic subcategorization. However, samples other than blood were 193 
not available in the present study. Cross-reactivity in serologic assays between Brucella spp. 194 
and Yersinia enterocolitica is well-documented (Ahvonen et al. 1969; Corbel and Dag 1973; Bundle 195 
et al. 1984). However, in a study of seals and whales, both being polar bear prey, no cross reactivity 196 
between Brucella spp. and Y. enterocolitica was found (Tryland et al. (1999). These data strongly 197 
suggest that any observed antibody titres in muskoxen and polar bears of the present study were due 198 
to Brucella spp. infection. 199 
 It is a general assumption that brucellosis is transmitted to polar bears through ingestion of 200 
infected seals, whale or muskoxen (Tryland et al. 2001). In Alaska, Brucella spp. found in polar bears 201 
were found likely to be of terrestrial origin (O’Hara et al. (2010). Altogether, this suggest that the 202 
detected polar bear Brucella spp. antibodies found in the present investigation were due to either prey 203 
spill over or true Brucella spp. infections (Fraser 1991; Tryland et al. 2001). Further studies are 204 
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therefore needed to address if Brucella spp. infections circulates among Greenland polar bears and 205 
whether it is associated with any pathology. Such investigations would allow a better prediction of 206 
Brucella spp. exposure and its significance for the health of North West Greenland polar bears. 207 
Evidence of brucellosis in muskoxen is sparse. In consistency with our findings, an analysis of 208 
132 muskoxen from North East Greenland in 1982 to 1983 revealed a seroprevalence for Brucella 209 
spp. of 0% (Clausen and Hjort 1986). On the other hand, Nymo et al. (2016) found recurring Brucella 210 
spp. antibody titres over time when analysing 52 muskoxen from Alaska (1982-2010). The 211 
seropositive muskoxen were from a part of Alaska with a high prevalence of Brucella spp. 212 
seropositive caribou (Zarnke et al. 2006). However, the North East Greenland muskox population is 213 
geographically isolated, and thus no spill over from other Arctic ungulate populations is likely to take 214 
place. 215 
Serological screenings conducted in the North Atlantic and Greenland Sea indicate that 216 
brucellosis has a wide geographical distribution among marine mammals including e.g. seal spp. 217 
(Nielsen et al. 1996; Prenger-Berninghoff et al. 2008; Tryland et al. 1999, 2005). Greenland, with its 218 
subsistence hunters and marine predator interactions (e.g. polar bears and seals), comprises a unique 219 
opportunity to study the occurrence of zoonotic diseases in a One Health perspective while tying 220 
together human and ecological and wildlife health. Brucellosis is in general a major public health 221 
concern worldwide (Ross et al. 1996; Tryland et al. 2013). The presence of antibodies against 222 
Brucella spp. in polar bears shows that these predators are exposed to the bacterium, although the 223 
prevalence seems low (6.3%), but not if it is true infections or spill over from prey exposure. Only in 224 
the case of true infections present a significant zoonotic potential for those who are handling or hunted 225 
polar bears and consuming their meat. There was however no evidence of Brucella spp. exposure in 226 
East Greenland muskoxen, which indicates that they are likely not affected by Brucella spp. infections 227 
and thereby not presenting a risk in terms of being a source of zoonotic Brucella infection for handlers 228 





Since all 32 analysed muskoxen were seronegative, the East Greenland population of the species 232 
seems to be free from brucellosis. 6.3% of the 96 polar bears analysed were seropositive either due 233 
to prey spill over or due to recurrent Brucella spp. infections. There was no clear association between 234 
seropositivity and age or biometric parameters i.e. size and body condition of polar bears. We suggest 235 
further studies on the distribution and taxonomic characterisation of Brucella spp. in Greenland, to 236 
better understand their potential harmful effects on wildlife populations as well as their zoonotic 237 
potential. 238 
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Table 1. Year and biometrics (weight, body condition and standard length) for the 96 West Greenland polar bears immobilised and serum sampled 441 
during 2009-2013. COYs: cub of the year, F: females, M: males. Weight: estimate body weight based on Derocher and Wiig (2002). Condition: 442 
body condition (1-5). SL: Standard length. Blanks: age/sex groups not immobilised and sampled.  443 
 2009 2010 2011 2012 2013 
 Mean±SD (n) Min-Max (n) Mean±SD (n) Min-Max (n) Mean±SD (n) Min-Max (n) Mean±SD (n) Min-Max (n) Mean±SD (n) Min-Max (n) 
COYs F           
Weight (kg)     21.65 (1) 21.65 (1) 18.00 (1) 18.00 (1)   
Condition (1-5)     3 (1) 3 (1) 2 (1) 2 (1)   
SL (cm)     93 (1) 93 (1) 89.5 ± 3.54 (2) 87-92 (2)   
COYs M           
Weight (kg)       17.09±5.12 (2) 13.5-20.7 (2)   
Condition (1-5)       3 (2) 3-3 (2)   
SL (cm)       87±5.66 (2) 83-91 (2)   
Yearlings F           
Weight (kg)   72.6±14.9 (2) 62-83.2 (2) 85±13.4 (2) 75.5-94.5 (2) 108.6±10.8 (2) 100.9-116.2 (2) 57.8 (1) 57.8 (1) 
Condition (1-5)   3 (2) 3-3 (2) 3 (2) 3-3 (2) 3 (3) 3-3 (2) 3 (1) 3 (1) 
SL (cm)   140.5±10.6 (2) 133-148 (2) 155.5±3.54 (2) 153-158 (2) 159±2.8 (2) 157-161 (2) 134 (1) 134 (1) 
Yearlings M           
Weight (kg)   104.5±21.9 (2) 89-120 (2) 117.9±17.9 (2) 105.1-130.5 (2)     
Condition (1-5)   3 (2) 3-3 (2) 3 (2) 3-3 (2)     
SL (cm)   154±9.9 (2) 147-161 (2) 167.5±4.9 (2) 164-171 (2)     
Two-year-old F           
Weight (kg) 131.2±29.6 (2) 110.3-152.1 (2) 160.7 (1) 160.7 (1) 115.9 (1) 115.9 (1)     
Condition (1-5) 3 (2) 3-3 (2) 3 (1) 3 (1) 3 (1) 3 (1)     
SL (cm) 169.5±12.0 (2) 161-178 (2) 179.0 (1) 179.0 (1) 167.0 (1) 167.0 (1)     
Two-year-old M           
Weight (kg) 149.2 (1) 149.2 (1)   182.6 (1) 182.6 (1) 136.3±43.4 (2) 105.6-167.0 (2)   
Condition (1-5) 3 (1) 3 (1)   3 (2) 3-3 (2) 3 (2) 3 (2)   
SL (cm) 184 (1) 184 (1)   182 (1) 182 (1) 169±15.6 (2) 158-180 (2)   
Subadults F           
Age (years) 4 (1) 4 (1) 3 (1) 3 (1) 2.5±0.71 (2) 2-3 (2) 3 (2) 3-3 (2)   
Weight (kg) 132.7 (1) 132.7 (1) 147.5 (1) 147.5 (1) 131±11.3 (2) 123-139 (2) 191.2±46.9 (2) 158-224.4 (2)   
Condition (1-5) 3 (1) 3 (1) 3 (1) 3 (1) 2.5±0.71 (2) 2-3 (2) 2 (2) 2-2 (2)   
SL (cm) 182 (1) 182 (1) 174 (1) 174 (1) 174.5±6.36 (2) 170-179 (2) 188±24 (2) 171-205 (2)   
Subadults M           
Age (years) 4 (1) 4 (1) 3.25±1.26 (4) 2-5 (4) 4±1 (3) 3-5 (3) 5 (1) 5 (1)   
22 
 
Weight (kg) 214.0 (1) 214.0 (1) 192.1±32.1 (4) 161.7-234.1 (4) 232.9±12.7 (3) 225-247.6 (3) 283.2 (1) 283.2 (1)   
Condition (1-5) 3 (1) 3 (1) 2.5±0.58 (4) 2-3 (4) 3±1 (3) 2-4 (3) 2 (1) 2 (1)   
SL (cm) 198 (1) 198 (1) 192.5±8.96 (4) 184-205 (4) 208±12.49 (3) 194-218 (3) 222 (1) 222 (1)   
Adult F           
Age (years) 9.6±5.13 (5) 6-17 (5) 13.25±3.73 (8) 5-16 (8) 9.7±3.9 (11) 5-15 (11) 7.44±2.46 (9) 5-12 (9) 9 (1) 9 (1) 
Weight (kg) 194.9±19.0 (5) 170.1-221.6 (5) 229.2±30.4 (8) 176.6-260 (8) 208±15.8 (11) 172.8-227.9 (11) 201.4±27.1 (9) 150.4-232.6 (9) 221.2 (1) 221.2 (1) 
Condition (1-5) 2.4±0.55 (5) 2-3 (5) 2.63±0.52 (8) 2-3 (8) 2.8±0.6 (11) 2-4 (11) 2.55±0.53 (9) 2-3 (9) 2 (1) 2 (1) 
SL (cm) 202.8±2.39 (5) 199-205 (5) 198.8±4.8 (8) 194-207 (8) 198.3±5.62 (11) 188-207 (11) 196.7±6.34 (9) 184-203 (9) 205 (1) 205 (1) 
Adult M           
Age (years) 11.4±6.6 (5) 6-20 (5) 15.7±7 (3) 9-23 (3) 11.7±5.7 (7) 6-24 (7) 13.2±3.56 (5) 9-17 (5) 9 (1) 9 (1) 
Weight (kg) 379.0±66.3 (5) 283.8-439.0 (5) 358.1±74.6 (3) 276.2-422.1 (3) 382.6±61.3 (7) 270.7-438.8 (7) 409.6±28 (5) 378.4-451.5 (5) 331 (1) 331 (1) 
Condition (1-5) 2.8±1.1 (5) 1-4 (5) 2.33±0.58 (3) 2-3 (3) 2.57±0.53 (7) 2-3 (7) 3.4±0.55 (5) 3-4 (5) 3 (1) 3 (1) 




Table 2. Biological information of the 32 East Greenland muskoxen immobilised and serum sampled 445 
in 2013 and 2015. Males were not immobilised and sampled in 2015. F: females, M: males 446 
 447 
  448 
  2013 2015 
  Mean±SD (n) Min-Max Mean±SD (n) Min-Max 
Adult F Weight 188.5±16.7 (13) 146-209 197.5±12.2 (14) 171.3-211.3 
 Condition 4±0 4-4 4±0 4-4 
Adult M Weight 268±18 (5) 246-292 -  
 Condition 4±0 4-4   
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FIGURE LEGENDS 449 
 450 
Figure 1. Map showing the sample sites, numbers and years for North West Greenland polar bears 451 
and North East Greenland muskoxen included in the present study.  452 
 453 
Figure 2. Seroprevalence for Brucella spp. among 96 North West Greenland polar bears sampled 454 
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